Home › Research › Tau biomarkers
The Diagnostic Role of FDG-PET in Dementias Presenting with Language and Behavioral Symptom
Yetim E, Ayhan Y, Yildirim MA, Volkan-Salanci B, Ergün EL, Çakmakli GY.. Turk psikiyatri dergisi = Turkish journal of psychiatry, 2026-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective This study aimed to assess the diagnostic contribution of Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in neurodegenerative dementias presenting with language-predominant symptoms, with or without accompanying behavioral changes, and to evaluate the correspondence between PET-derived metabolic patterns and cerebrospinal fluid (CSF) biomarkers. Methods Sixteen patients with language-predominant onset were categorized into two groups: Alzheimer’s disease (AD) spectrum (n=8) and the frontotemporal lobar degeneration (FTLD) spectrum (n=8). All participants underwent clinical evaluation, neuropsychological testing, and FDG-PET imaging.
What this study adds
Evidence grade: Low
In 16 patients with language-predominant dementia symptoms, this study assessed how FDG-PET contributed to diagnosis and how PET metabolic patterns corresponded with cerebrospinal fluid biomarkers. The sample is very small, and the work addresses diagnosis rather than treating, curing, or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Yetim, E., Ayhan, Y., Yildirim, M. A., Volkan-Salanci, B., Ergün, E. L., & Çakmakli, G. Y. (2026). The Diagnostic Role of FDG-PET in Dementias Presenting with Language and Behavioral Symptom. Turk psikiyatri dergisi = Turkish journal of psychiatry. https://doi.org/10.5080/u27876
Vancouver
Yetim E, Ayhan Y, Yildirim MA, Volkan-Salanci B, Ergün EL, Çakmakli GY. The Diagnostic Role of FDG-PET in Dementias Presenting with Language and Behavioral Symptom. Turk psikiyatri dergisi = Turkish journal of psychiatry. 2026. doi:10.5080/u27876. PMID: 42768871.
BibTeX
@article{yetim2026-42768871,
author = {Yetim, E. and Ayhan, Y. and Yildirim, M. A. and Volkan-Salanci, B. and Ergün, E. L. and Çakmakli, G. Y.},
title = {{The Diagnostic Role of FDG-PET in Dementias Presenting with Language and Behavioral Symptom}},
journal = {Turk psikiyatri dergisi = Turkish journal of psychiatry},
year = {2026},
doi = {10.5080/u27876},
pmid = {42768871},
url = {https://doi.org/10.5080/u27876}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Methods Sixteen patients with language-predominant onset were categorized into two groups: Alzheimer’s disease (AD) spectrum (n=8) and the frontotemporal lobar degeneration (FTLD) spectrum (n=8).
- All participants underwent clinical evaluation, neuropsychological testing, and FDG-PET imaging.
- Cerebrospinal fluid biomarkers [Amyloid Beta (Aβ42), total tau, and phosphorylated tau] were analyzed in eligible individuals (n=6).
- The two groups were compared across demographic, clinical, and neuroimaging parameters.
Why it matters
In 16 patients with language-predominant dementia symptoms, this study assessed how FDG-PET contributed to diagnosis and how PET metabolic patterns corresponded with cerebrospinal fluid biomarkers. The sample is very small, and the work addresses diagnosis rather than treating, curing, or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 28/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record and institution's track record, so those were left out: it earned 26 of the 93 points we could judge it on, which is 28 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Turk psikiyatri dergisi = Turkish journal of psychiatry) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Gül Yalçın Çakmaklı: h-index 14 (OpenAlex, whole career) |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42768871) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 26 / 93 | Scored on 18 of 20 parts. We have no data for the rest, so they are left out: 26 of the 93 points we could judge it on is 28 out of 100. |
| Total | 28 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.5080/u27876
- PubMed: 42768871
- Original source →
- Free full text: Turkish Journal of Psychiatry →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Tau biomarkers from nearby years
Also tagged “machine”
834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.